Search filters

Filters
Clear All

Phase

  • 18
  • 63
  • 42
  • 80
  • 13
  • 93
  • 13
  • 581
  • 934
  • 404
  • 12
  • 45
  • 881
  • 931
  • 7
  • 20
  • 918

Found 938 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
18 years or above
All genders
Phase 1/2
Interventional
This study investigates the condition of locally advanced or metastatic solid tumors. It evaluates an investigational medication to understand its effects on this particular health issue.The purpose of this study is to evaluate the safety and effectiveness of the investigational medication. It assesses how well the medication is tolerated and …
18 years or above
All genders
Phase 2
Interventional
This study investigates relapsed or refractory multiple myeloma.The study evaluates the effectiveness of an investigational medication in participants who have received at least three prior lines of therapy.Who can participate: Participants must have a documented diagnosis of multiple myeloma and have received at least three prior lines of therapy. They …
18 years or above
All genders
Phase 2/3
Interventional
This study investigates non-small cell lung cancer. This study looks at how adding an investigational medication to the usual treatment affects patients with this condition.The study evaluates the safety and effectiveness of the investigational medication when used with standard treatments. It observes how well the treatment works and any side …
99 years or below
All genders
PhenoTA proposes an automated solution for T, B, and NK cells, as well as other cell enumeration, identification and conditions, leveraging Raman spectroscopy, instead of traditional immunophenotypic and morphologic evaluation. This innovation aligns with the growing demand for rapid, cost-effective immunophenotyping and has the potential to transform standard hematology practice …
18 years or above
All genders
Phase 1/2
Interventional
The purpose of this study is to investigate relapsed or refractory multiple myeloma. This study investigates the condition in participants who have previously received specific treatments.This study evaluates the safety and tolerability of an investigational medication in participants. It focuses on understanding how the medication is processed by the body …
18 years or above
All genders
Phase 2
Interventional
The purpose of this study is to investigate relapsed or refractory multiple myeloma. It evaluates the effects of combining inobrodib with pomalidomide and dexamethasone.This study evaluates the safety and effectiveness of the investigational medication inobrodib when used with other medicines. It looks at how the combination affects patients with the …
99 years or below
All genders
The purpose of this program is to be able to provide patients with the drug mezigdomide (CC-92480) for the treatment of multiple myeloma. The reason for treating patients using this program is because they fit one or more of the following criteria: Patient has a serious or immediately life-threatening disease …
99 years or below
All genders
This is a surgical clinical registry to provide clinical information with the intent of measuring and improving quality. Our aim is to track and analyze osseointegration outcomes and complications of osseointegration percutaneous implant devices in upper and lower extremity amputees to determine long term prognosis, factors influencing infection risk, failure …
99 years or below
All genders
This study investigates the use of FAPI-74 PET/CT in adults with gastric or esophageal cancer. The purpose is to explore the diagnostic performance of this imaging technique.The study focuses on evaluating how well FAPI-74 PET/CT detects metastatic disease in these conditions. It assesses the effectiveness and accuracy of this imaging …
99 years or below
All genders
This study investigates ovarian cancer. The purpose of this study is to compare the investigational medication, Sofetabart Mipitecan, with standard chemotherapy or other treatments for ovarian cancer.The study evaluates the effectiveness and safety of Sofetabart Mipitecan in treating ovarian cancer compared to current standard treatments.Who can participate: Participants must be …
921 - 930 of 938